BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kwon JH, Lee N, Park JY, Yu YS, Kim JP, Shin JH, Kim DS, Joh JW, Kim DS, Choi KY, Kang KJ, Kim G, Moon YH, Wang HJ. Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma. PLoS One 2013;8:e64260. [PMID: 23785399 DOI: 10.1371/journal.pone.0064260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Parimbelli E, Marini S, Sacchi L, Bellazzi R. Patient similarity for precision medicine: A systematic review. J Biomed Inform 2018;83:87-96. [PMID: 29864490 DOI: 10.1016/j.jbi.2018.06.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 9.8] [Reference Citation Analysis]
2 Su Y, Ng K, Yu M, Wu T, Yeh T, Lee W, Lin Y, Hsieh T, Lin C, Yeh C, Chen T. Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas: Epidermal growth factor receptor in hepatomas. J Gastroenterol Hepatol 2015;30:1397-404. [DOI: 10.1111/jgh.12944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Thaiss W, Kaufmann S, Kloth C, Nikolaou K, Bösmüller H, Horger M. VEGFR-2 expression in HCC, dysplastic and regenerative liver nodules, and correlation with pre-biopsy Dynamic Contrast Enhanced CT. European Journal of Radiology 2016;85:2036-41. [DOI: 10.1016/j.ejrad.2016.09.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Voinsky I, Bennuri SC, Svigals J, Frye RE, Rose S, Gurwitz D. Peripheral Blood Mononuclear Cell Oxytocin and Vasopressin Receptor Expression Positively Correlates with Social and Behavioral Function in Children with Autism. Sci Rep 2019;9:13443. [PMID: 31530830 DOI: 10.1038/s41598-019-49617-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Shih YH, Lin XZ, Yeh CH, Peng CL, Shieh MJ, Lin WJ, Luo TY. Preparation and therapeutic evaluation of (188)Re-thermogelling emulsion in rat model of hepatocellular carcinoma. Int J Nanomedicine 2014;9:4191-201. [PMID: 25214783 DOI: 10.2147/IJN.S66346] [Reference Citation Analysis]
6 Yu XN, Chen H, Liu TT, Wu J, Zhu JM, Shen XZ. Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway? Biochim Biophys Acta Rev Cancer 2019;1871:379-91. [PMID: 30951815 DOI: 10.1016/j.bbcan.2019.03.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kim CM, Hwang S, Keam B, Yu YS, Kim JH, Kim DS, Bae SH, Kim GD, Lee JK, Seo YB, Nam SW, Kang KJ, Buonaguro L, Park JY, Kim YS, Wang HJ. Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker. Liver Cancer 2020;9:182-92. [PMID: 32399432 DOI: 10.1159/000504548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Bouattour M, Raymond E, Qin S, Cheng AL, Stammberger U, Locatelli G, Faivre S. Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 2018;67:1132-49. [PMID: 28862760 DOI: 10.1002/hep.29496] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 25.8] [Reference Citation Analysis]
9 Moldogazieva NT, Zavadskiy SP, Sologova SS, Mokhosoev IM, Terentiev AA. Predictive biomarkers for systemic therapy of hepatocellular carcinoma. Expert Rev Mol Diagn 2021;:1-18. [PMID: 34582293 DOI: 10.1080/14737159.2021.1987217] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Galmiche A, Chauffert B, Barbare JC. New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma. Cancer Lett 2014;346:159-62. [PMID: 24380851 DOI: 10.1016/j.canlet.2013.12.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
11 Teutonico D, Musuamba F, Maas HJ, Facius A, Yang S, Danhof M, Della Pasqua O. Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques. Pharm Res 2015;32:3228-37. [PMID: 25994981 DOI: 10.1007/s11095-015-1699-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]